CompletedNot Applicable

Prevalence of Subclinical Atrial Fibrillation in Heart Failure Patients and Its Relationship With Hospital Readmission

Canada242 participantsStarted 2018-03-24

Plain-language summary

Multicentre, prospective cohort study in patients with a history of HF with preserved or reduced ejection fraction admitted to hospital with acutely decompensated HF. Eligible and consenting patients will be enrolled at 3 Hamilton, Ontario area hospitals and receive 28-day ECG monitoring implemented at the time of hospital discharge. Patients will be followed for a total of 1 year from hospital discharge.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Hospitalized with a most responsible diagnosis of acute decompensated heart failure.
✓. Clinical signs and symptoms of heart failure as per the Boston criteria (i.e. score ≥8)

Exclusion criteria

✕. History of clinical atrial fibrillation
✕. History of hypertrophic cardiomyopathy or congenital heart disease.
✕. End stage renal disease or advanced renal dysfunction (e.g. estimated glomerular filtration rate, eGFR \< 15 mL/min/1.73 m2)
✕. Cardiothoracic surgery in the past 30 days or imminently planned (does not include percutaneous procedures).
✕. Unable or unwilling to provide informed consent.
✕. Presence of a pacemaker or an ICD with an atrial lead (which can already diagnose AF).

What they're measuring

Subclinical atrial fibrillation ≥30 minutes in duration

Timeframe: 30 days post-discharge

Trial details

NCT IDNCT03541616

SponsorPopulation Health Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-01-31

View on ClinicalTrials.gov More Heart Failure trials